Featured Events!


2019 Pre-Filled Syringes Forum, Boston

2019 Pre-Filled Syringes & Auto Injectors Forum

February 27-28, 2019, Metro Meeting Centers, Boston, MA

With the Pre-Filled Syringes market expected to top $16 billion dollars by 2021, the industry is looking for next generation materials, technologies and production strategies to streamline commercialization and to adapt quickly to a changing regulatory environment. Pharma Ed Resources, an industry leader since 2004 in delivering market-driven research on PFS, is proud to announce its 2019 Pre-Filled Syringes Forum. Pharma Ed brings together top scientists, regulatory experts and innovators to share best practices and the latest research in this field, enabling you to maximize your organization's leverage in this dynamic and growing market.

Featuring Representation From:

  • Biogen
  • Genentech
  • Allergan
  • Bristol-Myers Squibb
  • GSK
  • Sanofi Genzyme
  • Janssen R&D
  • Merck
  • Shire
  • Ompi
  • MedImmune
  • Ypsomed AG
  • PTI
  • Datwyler
  • Toxikon
  • Bosch
  • West
  • Unchained Labs
  • GessNet
  • Zeon

Featuring Comprehensive Coverage On:

  • Next Generation Materials & Design of Pre-Filled Syringes
  • Understanding Regulatory Requirements for PFS and Auto Injectors
  • Latest Auto-Injector Designs, including Wearable-Injector Devices, Pen Injectors, Bolus Injectors, and Patch Pumps
  • QbD Applications in the Manufacture of Pre-Filled Syringes
  • Leachables and Safety Considerations in Pre-Filled Syringes
  • Extractables and Leachables - Toxicological Perspectives on ICH M, and other Guidelines for Efficient Product Development
  • Improving Drug Stability in Pre-Filled Syringes
  • Pre-Filled Syringes vs. Single Dose Cartridges
  • Optimizing Aseptic Filling Processes, Including Automated Inspection
  • Challenges in the Use of PFS for Biologics

Silver Sponsor:

Event Sponsors:

Media Partner:


Data Integrity & Pharmaceutical Quality Compliance Summit

March 4-5, 2019, Metro Meeting Center, Boston, MA

Featuring In-Depth Coverage On:

  • Regulatory Guidance for Data Integrity
  • A Regulatory Global View on Data Integrity and its Importance
  • Examining FDA Integrity Guideline
  • Creating Data Integrity Programs
  • Data Integrity During Process Validation and Commerical Product Transfers
  • CMOs and Data Integrity
  • How to Detect the Lack of Data Integrity
  • Data Integrity for Complex Analytical Systems. How to Deal Effectively with Vendor-Provided COTS Solutions?
  • Data Integrity in cGMP realized in global Pharma corporate projects
  • Performing a Risk Assessment for Data Deficiencies
  • Data Lifecycle Management
  • Process Validation and Technology Transfer of Biologics and Vaccines
  • Software Validation Case Study: Validation of MES System

With Representation From:


Extractables, Leachables & Elemental Impurities 2019

Ensuring Quality, Safety, Suitability and Regulatory Compliance for Drugs, Biologics and Medical Devices

April 10-11, 2019, Metro Meeting Center, Boston, MA

This two-day conference will examine the safety, quality, and regulatory issues involved in a wide array of contexts central to the pharmaceutical and biotech industries, including drug packaging and delivery components, single-use systems, medical devices, and parenteral drug products. In addition, we will focus closely on the keys to satisfying recent ICH and USP guidelines for metal impurities in current and future drug products and biologics; recent revisions to USP chapters; and the recently revised standards contained in ISO 10993.

Featuring In-Depth Coverage On:

  • Implementing ICH Q3D, and USP Guidelines Regarding Elemental Impurities: Case Studies and Regulatory Expectations
  • Update on ongoing revisions to USP and for Materials and Components used in Pharmaceutical Manufacturing Systems
  • Update on ongoing revisions to ISO 10993 Revised Standards for Medical Devices
  • Meeting Regulatory Expectations for E&Ls in Drug Products, Delivery Systems, and Medical Devices
  • The Proper Use of Extractables Data
  • Toxicology Assessment Approaches for E&L Studies
  • E&L Best Practices for Inhaled Products and Inhalation Devices
  • E&L Best Practices for Medical Devices & Combination
  • Designing and Improving Risk-Based Assessment of E&L Data for Drugs, Biologics, and Medical Devices
  • GC-MS Applications for Detection of Leachables
  • Exploring Biocompatibility Vs. Chemical Assessment in E&L Study Design
  • E&L Evaluation for Complex Pharmaceutical Formulations
  • Issues Frequently Observed in Analytical Evaluation of Leachables in Drug Products
  • E&L Considerations in the Qualification and Validation of Single-Use Systems
  • E&L Best Practices for Oral Dosage Forms
  • Understanding Leaching Associated with Lyophilized Drug
  • Products Stored in Vial/Stopper Packaging Systems
  • Addressing E&Ls from Bioprocessing Equipment & Product Packaging

With Representation From:

  • FDA (pending approval)
  • PPD
  • Sartorius Stedim
  • VR Analytical
  • Fresenius Medical Care
  • Intertek
  • Med Institute
  • Triad Scientific Solutions
  • Nitto Avecia
  • Knoell Germany GmbH
  • Material Needs Consulting
  • Smithers
  • Exova
  • Eakins & Associates
  • Risk Science Consortium

Event Sponsors:

Media Sponsors:

Register before January 10 to receive $300 off the standard rate!


Inhalation Drug Delivery Systems 2019

May 28-29, 2019, Boston, MA

Featuring In-Depth Coverage On:

  • Regulatory Compliance Issues for Inhalation Therapies
  • Combination Product Design
  • Achieving An Inhaled Insulin Product
  • Developing A Generic Inhaled Product
  • Sterilization Issues Surrounding Inhalation Therapies
  • Extractables and Leachables Testing
  • Nebulizers, E-Cigarettes and Vaporizers: Past, present and future
  • Alternative Therapeutic Fields: Inhaled Antibiotics
  • Future directions in inhalation and respiratory drug delivery research
  • Novel Technologies For Pulmonary And Nasal Delivery
  • The Challenge Of Developing Inhalation Devices
  • Applying QbD Principles to Inhalation Therapies
  • Improving Patient Adherence With Product Design
  • And more!

With Representation From:

  • Genentech
  • Merck
  • GSK
  • Aptar
  • Smithers
  • Harro Hofliger
  • Nelson Labs
  • Exova
  • Intertek
  • Toxikon
  • EKG Labs
  • Material Needs Consulting
  • Vas Analytical
  • University of Florida
  • University of Texas

Event Sponsors:

Media Partner:

Early Bird Special: Register by December 15 to save $200.


2019 Process Validation Summit

June 12-13, 2019, Sheraton La Jolla, CA

Are you compliant with FDA requirements for process validation? Today's regulators are applying more fine-grained specifications and demanding more sophisticated procedures for planning, executing, and documenting your processes throughout a drug product's lifecycle. This two-day intensive summit brings together industry leaders to help you exceed regulatory thresholds and avoid costly FDA inspection findings.

With Representation From:

  • AstraZeneca
  • Bristol-Myers Squibb
  • Bausch + Lomb
  • Celgene
  • Alphora
  • Jubilant Pharma
  • VTI Life Sciences
  • Charles River Laboratories
  • Pharmatech Associates
  • SynoloStats
  • VolPal
  • Shook, Hardy & Bacon
  • Compliance Team, Inc.
  • Caliber Therapeutics
  • Beckman Coulter
  • Alcon
  • STERIS

With Comprehensive Coverage On:

  • Introduction to Recent Advances in Process Validation - Life Cycle Approach
  • Regulations/ICH Guidance/FDA, EU perspective/PV, life cycle approaches
  • Validation in the Biopharmaceutical Industry
  • Continued Process Verification (stage 3) approaches, understanding & realization
  • Quality-by-Design, PAT, Quality Risk Management - new product vs. legacy
  • Statistical Process Control & Sampling Plans
  • Global Tech Transfers and Process Validation Approaches
  • Process Validation Biologics vs. Biosimilars, Biobetters
  • Business Perspectives on PV
  • Process Validation Biologics vs. Biosimilars, Biobetters, OTC Manufacturing
  • Enhanced Sampling in Process Performance Qualification and Continued Process Verification
  • Systematic Method for Process Development and Successful Implementation Based on Lessons Learned
  • Process Validation as the Bridge from Clinical to Commercial
  • Statistical Methods for Small-Scale Model Qualification in Bioprocessing
  • Benefits of Establishing a True End-to-End, Close to Real-time Robustness Monitoring Program
  • And Much More!

Early Bird Special: Register by February 1st!!



Upcoming Events

Transdermal Drug Delivery Systems- September 11th and 12th

Boston, MA

Cleaning Validation- September 26th and 27th

Boston, MA

Wearable Injectors- October 10th and 11th

Boston, MA

Cannabis and the Pharma Industry- October 24th and 25th

San Diego, California

Tentative Pre-Filled Syringes repeat in San Diego in mid-November

Boston, MA

Why PharmaEd?

Profitable Networking

Industry innovators and established professionals meet to share ideas, forge relationships, and imagine new opportunities.

Experience You Trust

Our team has over four decades of combined experience producing conferences and delivering real value to the pharma industry.

An Industry Leader

Pharma Ed has collaborated with over 250 companies and organizations to produce some of the most informative meetings in the industry.

Our Mission

To deliver the most current, market-driven information to meet your research, product development, regulatory, quality assurance, and technical needs.

Relevant Training

Cutting-edge knowledge drawn from top pharmaceutical, biotech, and academic experts.

Sponsorship Opportunities!

Sponsor a PharmaEd event and set your business apart!

CLICK HERE TO LEARN MORE

What People Are Saying About
Pharma Ed Events

"A Fantastic meeting. I was interested in so many of the talks and I met several clients - current and potential."
- Principal Scientist, Aptuit SSCI

"I really enjoyed the meeting... Stronger speakers and more in depth coverage than some of the others on the market."
- Director, Emerson Resources, Inc.

"Thank you again for such an excellent program - it was very informative and enjoyable."
- Sr. Principal Scientist, Bausch + Lomb

"I go to a lot of conferences, and this was an excellent one."
- Sr. Scientist, Boehringer Ingelheim

"Great audience, with good choice of speakers. Would love to attend again."
- Principal Scientist, Pfizer

"I greatly enjoyed the conference. I found the topics relevant and containing great content. I look forward to bringing the knowledge and principles to my role in R&D."
- Manager, CSL Behring

"I was very pleased with the material presented, and the expertise of the presenters. I will be taking much valuable/applicable knowledge back to my company."
- QA Director, Biothera

"Each and every presentation contained information that I found to be useful and relevant and many presentations left me with ideas and concepts that I look forward to considering in greater detail."
- Distinguished Scientist, Baxter

"The presentations & experience of the presenters was very instructive & helpful toward building my programs."
- QA/Corporate Director, Medicago, Inc.

"This is a valuable conference, with many expert speakers."
- Product Manager, EMD Millipore

"I really enjoyed it. I feel engaged and like there is a lot to learn."
- Assoc. Scientist, Bristol-Myers Squibb

"Very good conference with knowledgeable presenters, good feedback, and 'real world' examples/takeaways."
- Assoc. Director of PV, Shire

"Great mix of topics and excellent networking sessions."
- Deputy Director, Sanofi Pasteur

"Very useful conference for us. Learned a lot from all the presentations."
- Scientist I, Amneal Pharmaceuticals

"I am new to the med device E/L scene, so I attended as a learning opportunity and to begin to get up to speed. I feel the conference was very informative and balanced various subject areas as well. I'll definitely plan on attending again."
- Research Toxicologist, NSF International